Back to Agenda
Evolution of Medical and Device Writing
Session Chair(s)
Sarah Ellinwood, PhD
Associate Analyst, Medical Writer
VERGE Scientific Communications, United States
Dan Benau, PhD
Director, Biomedical Writing Programs
University of the Sciences, United States
Since the inception of formalized regulatory medical writing in the 1980s, the medical and pharmaceutical communication industries have changed dramatically. Next-generation technologies have produced massive datasets giving us a more holistic view of how a therapy, whether drug, biologic, or device, behaves. The problem is that this might have created possible information overload for HCPs and especially for patients. What have been some of the key inflection points in the history of medical writing and what can we expect moving forward? The speakers in this session will share their experiences and insights on the past, present, and future of medical writing with respect to the regulatory, promotional, and educational genres.
Learning Objective :
At the conclusion of this session, participants should be able to:
- Discuss the history of medical and device writing and how the fields have changed in response to evolving scientific understanding, trends, and technologies
- Identify and embrace opportunities to prepare for future trends and challenges in the field
- Initiate productive interactions with different medical writing audiences
Speaker(s)
Speaker
Rita P Francis, PhD, MS, PMP
University of the Sciences, United States
Adjunct Professor, Biomedical Writing Program
Speaker
Dan Benau, PhD
University of the Sciences, United States
Director, Biomedical Writing Programs
Have an account?